Showing 1 to 1 of 1 results
cnbc.com
🌐 75% Global Worthiness
GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities
A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...
GLP-1 Drug Adherence: Cost, Side Effects, and Income Disparities
A JAMA Network Open study reveals that 65% of patients without diabetes stopped using GLP-1 weight loss drugs within a year, compared to 46% of those with Type 2 diabetes; side effects and cost were the main reasons, while higher income and weight loss correlated with continued use; Noom's layoffs e...
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results